Basics BridgeBio Pharma, Inc. IPO Date: June 24, 2019 Sector: Healthcare Industry: Biotech Market Cap: $6.73B Activated in VL: True Average Daily Range Avg Daily Range: $0.84 | 3.13% Avg Daily Range (30 D): $0.66 | 1.90% Avg Daily Range (90 D): $0.83 | 2.47% Institutional Daily Volume Avg Daily Volume: 1.41M Avg Daily Volume (30 D): 2.66M Avg Daily Volume (90 D): 2.55M Trade Size Avg Trade Size (Sh.): 87 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 78 Institutional Trades Total Inst.Trades: 5,985 Avg Inst. Trade: $2.85M Avg Inst. Trade (30 D): $2.87M Avg Inst. Trade (90 D): $2.87M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $6.15M Avg Closing Trade (30 D): $12.65M Avg Closing Trade (90 D): $11.48M Avg Closing Volume: 238.76K     News May 2, 2025 @ 9:04 PM Alnylam Delivers Q1 Surprise, Analysts Highlight A... Source: Vandana Singh Apr 28, 2025 @ 9:00 AM BEYONTTRA® (acoramidis), the First Near-complet... Source: Bridgebio Pharma, Inc. Apr 15, 2025 @ 11:39 AM Is High-Yield Pfizer Stock Still a Buy After Scrap... Source: Cory Renauer Mar 21, 2025 @ 8:00 PM BridgeBio Pharma Reports Inducement Grants under N... Source: N/A Feb 26, 2025 @ 7:49 AM BridgeBio Prices Offering of $500 Million Converti... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.55 $-.88 $-1.42 Diluted EPS $-3.55 $-.88 $-1.42 Revenue $ 127.42M $ 116.63M $ 5.88M Gross Profit $ 121.5M $ 113.99M $ 3.8M Net Income / Loss $ -676.8M $ -169.61M $ -267.39M Operating Income / Loss $ -697.69M $ -104.37M $ -226.03M Cost of Revenue $ 5.92M $ 2.64M $ 2.08M Net Cash Flow $ 65.25M $ -140.5M $ 275.37M PE Ratio